PAM
SNOA icon

Panagora Asset Management’s Sonoma Pharmaceuticals SNOA Stock Holding History

Panagora Asset Management’s Portfolio SNOA Stock Details SNOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-28
Closed -$7K – 2515
2018
Q3 		$7K Sell
28
-38
-58% -$13.8K ﹤0.01% 2332
2018
Q2 		$30K Hold
66
– – ﹤0.01% 2137
2018
Q1 		$44K Buy
+66
New +$54.2K ﹤0.01% 2072

Other funds holding SNOA

SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
BA
Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
GW
GW & Wade Wellesley, Massachusetts $3.08B AUM 18.99% 1-Year Est. Return

Panagora Asset Management's SNOA Position: Q4 2018 in Review

Panagora Asset Management sold out of Sonoma Pharmaceuticals (SNOA) in Q4 2018, closing a stake of 28 shares — an estimated $7K sold.

Panagora Asset Management first reported a position in SNOA in Q1 2018 and held it in 3 quarters. The position peaked at $44K in Q1 2018. 18 funds tracked by Wall St. Rank hold SNOA as of Q4 2018.

  • Panagora Asset Management reported no remaining Sonoma Pharmaceuticals position as of Q4 2018 after selling out during the quarter.
  • Panagora Asset Management sold 28 Sonoma Pharmaceuticals shares in Q4 2018, an estimated $7K.
  • Panagora Asset Management first reported a position in Sonoma Pharmaceuticals in Q1 2018 and held it in 3 quarters.
  • Panagora Asset Management's Sonoma Pharmaceuticals position peaked at $44K in Q1 2018.
  • 18 funds tracked by Wall St. Rank held Sonoma Pharmaceuticals as of Q4 2018.

Based on Panagora Asset Management's 13F filing for Q4 2018, filed 14 Feb 2019.